Literature DB >> 9049041

C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.

T Werfel1, M Oppermann, G Begemann, O Götze, J Zwirner.   

Abstract

The expression of the receptor for the anaphylatoxin C5a on mast cells was studied with three monoclonal antibodies directed to the N-terminal domain of the C5a receptor. Human skin was investigated by immunohistology applied to sequential 2 micron sections of acrylate-embedded tissues. All anti-C5a receptor antibodies stained c-kit+ or tryptase+ cells which were metachromatic after toluidine blue staining in normal human skin. The binding of anti-C5a receptor antibodies was inhibitable by a peptide representing the first 31 amino acids of the C5a receptor. A similar expression of C5a receptors was found on mast cells in chronic psoriatic plaques. However, C5a receptors were not detectable on mast cells in weal and flare reactions or in lesional skin of uticaria pigmentosa. These findings suggest that (1) anti-C5a receptor antibodies directed to the N-terminal domain of the receptor are suitable tools for the identification of mast cells in acrylate-embedded sections of human skin, (2) mast cell activation in weal and flare reactions results in C5a receptor downregulation or receptor blockade and (3) mast cells in urticaria pigmentosa lack a typical marker of normal human skin mast cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049041     DOI: 10.1007/s004030050159

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

Review 1.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

2.  Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.

Authors:  K Kirchhoff; O Weinmann; J Zwirner; G Begemann; O Götze; A Kapp; T Werfel
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.

Authors:  Penmetcha K R Kumar
Journal:  Mol Biol Rep       Date:  2018-07-06       Impact factor: 2.316

4.  Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.

Authors:  E Fiebiger; F Hammerschmid; G Stingl; D Maurer
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 5.  Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases.

Authors:  Pavel Kolkhir; Daniel Elieh-Ali-Komi; Martin Metz; Frank Siebenhaar; Marcus Maurer
Journal:  Nat Rev Immunol       Date:  2021-10-05       Impact factor: 53.106

Review 6.  Complement anaphylatoxins as immune regulators in cancer.

Authors:  Eli T Sayegh; Orin Bloch; Andrew T Parsa
Journal:  Cancer Med       Date:  2014-04-08       Impact factor: 4.452

7.  Nerve Growth Factor Secretion From Pulp Fibroblasts is Modulated by Complement C5a Receptor and Implied in Neurite Outgrowth.

Authors:  Fanny Chmilewsky; Warda Ayaz; James Appiah; Imad About; Seung-Hyuk Chung
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

Review 8.  The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.

Authors:  Yu Wang; Hui Zhang; You-Wen He
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.